Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000078003-11-000013
Filing Date
2011-09-14
Accepted
2011-09-14 19:25:53
Documents
2
Period of Report
2011-09-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4663
2 EXHIBIT 99.1 ex99sig.htm EX-99 3750
  Complete submission text file 0000078003-11-000013.txt   10534
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Reporting) CIK: 0000078003 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-34217 | Film No.: 111091472
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 4222 EMPEROR BLVD SUITE 350 DURHAM NC 27703 919-941-5206
ICAGEN INC (Issuer) CIK: 0000902622 (see all company filings)

EIN.: 561785001 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 235 EAST 42ND ST. MS 235/19/2 NEW YORK NY 10017
Business Address 235 EAST 42ND ST. MS 235/19/2 NEW YORK NY 10017 2127332323
Eclipse Acquisition Corp. (Reporting) CIK: 0001529320 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-34217 | Film No.: 111091471